Search Results - Ballantyne, S.

  • Showing 1 - 10 results of 10
Refine Results
  1. 1
    New therapeutic principles in dyslipidaemia: Focus on LDL and Lp(a) lowering drugs

    New therapeutic principles in dyslipidaemia: Focus on LDL and Lp(a) lowering drugs by Norata, Giuseppe, Ballantyne, C., Catapano, A.

    Published 2013
    Get full text
  2. 2
    Recreational trails are an important cause of fragmentation in endangered urban forests: A case-study from Australia

    Recreational trails are an important cause of fragmentation in endangered urban forests: A case-study from Australia by Ballantyne, M., Gudes, Ori, Pickering, C.

    Published 2014
    Get full text
  3. 3
    The amplification of Arctic terrestrial surface temperatures by reduced sea-ice extentduring the Pliocene

    The amplification of Arctic terrestrial surface temperatures by reduced sea-ice extentduring the Pliocene by Ballantyne, A., Axford, Y., Miller, Gifford, Otto-Bliesner, B., Rosenbloom, N., white, J.

    Published 2013
    Get full text
    Get full text
  4. 4
    Troponin T, NT-proBNP, and Incidence of Stroke: The Atherosclerosis Risk in Communities (ARIC) Study

    Troponin T, NT-proBNP, and Incidence of Stroke: The Atherosclerosis Risk in Communities (ARIC) Study by Folsom, A., Nambi, V., Bell, E., Oluleye, O., Gottesman, R., Lutsey, P., Huxley, Rachel, Ballantyne, C.

    Published 2013
    Get full text
  5. 5
    Surface immobilisation of antibody on cyclic olefin copolymer for sandwich immunoassay

    Surface immobilisation of antibody on cyclic olefin copolymer for sandwich immunoassay by Raj, J., Herzog, G., Manning, M., Volcke, C., MacCraith, B., Ballantyne, S., Thompson, M., Arrigan, Damien

    Published 2009
    Get full text
  6. 6
    Troponin T, N-terminal pro-B-type natriuretic peptide, and incidence of stroke: The atherosclerosis risk in communities study

    Troponin T, N-terminal pro-B-type natriuretic peptide, and incidence of stroke: The atherosclerosis risk in communities study by Folsom, A., Nambi, V., Bell, E., Oluleye, O., Gottesman, R., Lutsey, P., Huxley, Rachel, Ballantyne, C.

    Published 2013
    Get full text
  7. 7
    High-Sensitivity Cardiac Troponin T and the Risk of Incident Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study

    High-Sensitivity Cardiac Troponin T and the Risk of Incident Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study by Filion, K., Agarwal, S., Ballantyne, C., Hoogeveen, R., Huxley, Rachel, Loehr, L., Nambi, V., Soliman, E., Alonso, A.

    Published 2011
    Get full text
  8. 8
    Blood lipid levels, lipid-lowering medications, and the incidence of atrial fibrillation: The atherosclerosis risk in communities study

    Blood lipid levels, lipid-lowering medications, and the incidence of atrial fibrillation: The atherosclerosis risk in communities study by Lopez, F., Agarwal, S., MacLehose, R., Soliman, E., Sharrett, A., Huxley, Rachel, Konety, S., Ballantyne, C., Alonso, A.

    Published 2012
    Get full text
  9. 9
    High-sensitivity cardiac troponin T and the risk of incident atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study

    High-sensitivity cardiac troponin T and the risk of incident atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study by Filion, K., Agarwal, S., Ballantyne, C., Eberg, M., Hoogeveen, R., Huxley, Rachel, Loehr, L., Nambi, V., Soliman, E., Alonso, A.

    Published 2015
    Get full text
  10. 10
    Temporal Flows

    Temporal Flows by Basson, Steve

    Published 2012
    Other Authors: “…Andrew Ballantyne…”
    Get full text

Search Tools: